Cargando…
Raloxifene improves skeletal properties in an animal model of cystic chronic kidney disease
Patients with chronic kidney disease (CKD) have an increased risk of fracture. Raloxifene is a mild anti-resorptive agent that reduces fracture risk in the general population. Here we assessed the impact of raloxifene on the skeletal properties of animals with progressive CKD. Male Cy/+ rats that de...
Autores principales: | Newman, Christopher L., Creecy, Amy, Granke, Mathilde, Nyman, Jeffry S., Tian, Nannan, Hammond, Max A., Wallace, Joseph M., Brown, Drew M., Chen, Neal, Moe, Sharon M., Allen, Matthew R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840093/ https://www.ncbi.nlm.nih.gov/pubmed/26489025 http://dx.doi.org/10.1038/ki.2015.315 |
Ejemplares similares
-
Cortical Bone Mechanical Properties Are Altered in an Animal Model of Progressive Chronic Kidney Disease
por: Newman, Christopher L., et al.
Publicado: (2014) -
Effects of combination treatment with alendronate and raloxifene on skeletal properties in a beagle dog model
por: Allen, Matthew R., et al.
Publicado: (2017) -
Raloxifene Prevents Skeletal Fragility in Adult Female Zucker Diabetic Sprague-Dawley Rats
por: Hill Gallant, Kathleen M., et al.
Publicado: (2014) -
N-acetylcysteine (NAC), an anti-oxidant, does not improve bone mechanical properties in a rat model of progressive chronic kidney disease-mineral bone disorder
por: Allen, Matthew R., et al.
Publicado: (2020) -
Manipulating the Amount and Structure of the Organic Matrix Affects the Water Compartments of Human Cortical Bone
por: Nyman, Jeffry S, et al.
Publicado: (2019)